Barely Significant
← all phrases

“a numerical trend”

1,013 sentences · 1,013 papers · 1,817 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

However, inconsistent with this explanation, during training, target processing at the high-probability distractor location was not reliably impaired (although a numerical trend in this direction should be noted).
Visual statistical learning requires attention.
Psychon Bull Rev · 2025 · PMC12092514
Three key findings emerged (I) repeated G-CSF dosing induced a substantially stronger and more consistent neutrophil response in the peripheral blood, bone marrow than single-dose regimens, with a numerical trend towards increased neutrophil abundance also observed in the spleen, (II) single-dose administration resulted in only minor or non-significant effects regardless of the dose; and (III) neutrophil expansion occurred without evidence of systemic inflammation, as indicated by stable plasma NE activity and cfDNA levels across all groups. 3.2.
Response criterion (β) showed a numerical trend toward a more stringent criterion in the high load condition ( M = 14.1) than in the low load condition ( M = 7.7), but this was not significant, F (1, 20) = 2.69, MSE = 83.50, p = .117, η p 2 = .119.
Load induced blindness.
J Exp Psychol Hum Percept Perform · 2008 · PMC2672054
However, although there was no significant difference in VO 2 at the ventilatory threshold (LS mean difference, 0.6 mL/kg/min; 95% CI, −0.03 to 1.17 mL/kg/min; P = .06) between mavacamten and placebo in exploratory analyses that were not adjusted for multiplicity, a numerical trend toward improvement was observed ( Figure 3 ; Table 2 ).
The results of the evening group suggest that participants with an intervening night’s sleep between Session 1 (i.e., training session) and later sessions showed a numerical trend of improved ID performance in posttest2, and a marginally significant improvement in posttest3, compared with their ID performance in the initial posttest.
Results: This study revealed a numerical trend toward higher patient satisfaction with on-site consultations across both age groups, particularly among those aged 18-40, although the difference among patients aged >41 years was minimal; however, these differences were not statistically significant.
However, the conclusions of these 2 trials differed: MATTERHORN met its primary EFS endpoint and demonstrated a statistically significant benefit with durvalumab-based chemoimmunotherapy, whereas KEYNOTE-585 did not achieve a statistically significant improvement (HR = 0.81, 95% CI = 0.67 to 0.98), showing only a numerical trend favoring pembrolizumab-based therapy.